Cardiovascular Systems to Webcast Fiscal 2016 Second-Quarter Earnings Conference Call Thursday, January 21
By Business Wire News
By Business Wire News
ST. PAUL, Minn.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2016 second-quarter conference call on Thursday, January 21, 2016, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman and Interim President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal second quarter ended December 31, 2015, and its financial outlook. The company will issue a post-market earnings release prior to the call on January 21.
To access the live webcast, go to the investor section of the company’s website, www.csi360.com, on the day of the conference call and click on the webcast icon. A webcast replay will be available beginning at 6:45 p.m. CT the same day.
To participate in the conference call, dial (877) 201-0168 and enter 21694741. Please dial in at least 10 minutes prior to the call.
If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial (855) 859-2056 and enter 21694741. The audio replay will be available beginning at 6:45 p.m. CT on Thursday, January 21, 2016, through 10:59 p.m. CT on Thursday, January 28, 2016.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. To date, over 220,000 of CSI’s devices have been sold to leading institutions across the United States. For more information, visit the company’s website at www.csi360.com.